PD-1 antibody in combination with chemotherapy for the treatment of SMARCA4-deficient advanced undifferentiated carcinoma of the duodenum: Two case reports

doi:10.5306/wjco.v15.i3.456

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2005)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

HTML

1012

Figures (1-3)

137

Tables (1-1)

129

Sum=1331

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

133

Download

287

Sum=420

Publishing Process of This Article

Item

Count

Browse

Download

136

Sum=187

Mar 24, 2024 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Mar 24, 2024; 15(3): 456-463
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.456

Table 1 Genomic profile of somatic alterations for the patients

	Gene	Transcript description	Mutant allele frequency
Case 1	TP53	NM_000546.5:c.742C>T(p.Arg 248Trp)	20.9%
	CTNNB1	NM_001098209.1:c.134C>T(p.Ser45Phe)	23.4%
Case 2	TP53	NM_000546.5: c.1024C>T(p.R342)	23.2%
	NCOR1	NM_006311.3 :c.5689T>G (p.S1897A)	18.7%
	MYH9	NM_002473.4 : c.1560C[6>7] (p.I524Hfs*44)	15.9%
	ERBB3	NM_001982.3 : c.850G>C (p.G284R)	15.0%
	RAD52	NM_134424.2 : c.779G>A (p.R260Q)	14.8%
	CTNNB1	NM_001904.3 :c.133T>C (p.S45P)	14.2%

Citation: Shi YN, Zhang XR, Ma WY, Lian J, Liu YF, Li YF, Yang WH. PD-1 antibody in combination with chemotherapy for the treatment of SMARCA4-deficient advanced undifferentiated carcinoma of the duodenum: Two case reports. World J Clin Oncol 2024; 15(3): 456-463
URL: https://www.wjgnet.com/2218-4333/full/v15/i3/456.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i3.456